RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Alderline Group
A

Alderline Group portfolio

Alderline Group has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $52M.
Latest deal: Third Arc Bio · Feb 4, 2026.
About this page

Its most recent investment on record is Third Arc Bio's $52M Series A round in February 2026, alongside Aberdeen, Marshall Wace, Galapagos and 6 others. That company is in Health and bio.

What Alderline Group invests in

How Alderline Group invests

StageDealsCapital in rounds
Series A 1 100%$52M

Alderline Group portfolio companies

CompanyRound with Alderline GroupTotal raisedLatest raise
TThird Arc Bio
Health and bio
Series A · $52M$217MFeb 4, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Alderline Group. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Alderline Group, which is a subset of its real portfolio. API: /api/v1/investors/alderline-group (get a free API key). More: the most active VC firms and new venture capital funds.